Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Pourquier

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Bulletin Du Cancer|October 25, 2011
[Alkylating agents]Philippe Pourquier
Bulletin Du Cancer|August 28, 2018
[How to manipulate DNA repair to generate neoantigens and ameliorate the efficacy of immunotherapies]Philippe Pourquier
Bulletin Du Cancer|January 11, 2021
Philippe Pourquier
Bulletin Du Cancer|November 4, 2011
[Molecular determinants of response to topoisomerase I inhibitors]Philippe Pourquier, Amélie Lansiaux
Bulletin Du Cancer|August 28, 2019
[Neural progenitors of the brain migrate into prostate and breast tumors and promote tumour growth and metastasis]Hadjer Dellal, Philippe Pourquier
Bulletin Du Cancer|October 26, 2011
[Molecular determinants of response to topoisomerase II inhibitors]Amélie Lansiaux, Philippe Pourquier
Bulletin Du Cancer|January 1, 2019
[Genetic and transcriptional evolution alters cancer cell line drug response]Philippe Pourquier, Joëlle Azzi
Bulletin Du Cancer|July 25, 2022
[Molecular signatures in castration-resistant prostate cancers: An update]Nadine Houédé, Philippe Pourquier
Bulletin Du Cancer|March 19, 2011
[General overview on DNA repair]Philippe Pourquier, Jacques Robert
Pharmacology & Therapeutics|June 15, 2014
Targeting the genetic alterations of the PI3K-AKT-mTOR pathway: its potential use in the treatment of bladder cancersNadine Houédé, Philippe Pourquier
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Bulletin Du Cancer|October 25, 2011
[Alkylating agents]Philippe Pourquier
Bulletin Du Cancer|August 28, 2018
[How to manipulate DNA repair to generate neoantigens and ameliorate the efficacy of immunotherapies]Philippe Pourquier
Bulletin Du Cancer|January 11, 2021
Philippe Pourquier
Bulletin Du Cancer|November 4, 2011
[Molecular determinants of response to topoisomerase I inhibitors]Philippe Pourquier, Amélie Lansiaux
Bulletin Du Cancer|August 28, 2019
[Neural progenitors of the brain migrate into prostate and breast tumors and promote tumour growth and metastasis]Hadjer Dellal, Philippe Pourquier
Bulletin Du Cancer|October 26, 2011
[Molecular determinants of response to topoisomerase II inhibitors]Amélie Lansiaux, Philippe Pourquier
Bulletin Du Cancer|January 1, 2019
[Genetic and transcriptional evolution alters cancer cell line drug response]Philippe Pourquier, Joëlle Azzi
Bulletin Du Cancer|July 25, 2022
[Molecular signatures in castration-resistant prostate cancers: An update]Nadine Houédé, Philippe Pourquier
Bulletin Du Cancer|March 19, 2011
[General overview on DNA repair]Philippe Pourquier, Jacques Robert
Pharmacology & Therapeutics|June 15, 2014
Targeting the genetic alterations of the PI3K-AKT-mTOR pathway: its potential use in the treatment of bladder cancersNadine Houédé, Philippe Pourquier
Pageof 8